Description: Inflammasome Therapeutics is a science-based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration and type 2 diabetes.
treatment (2760) patents (562) multiple sclerosis (268) macular degeneration (173) type 2 diabetes (105) alzheimer’s disease (34) inflammasome (6) kamuvudines (2)
Inflammasome Therapeutics is focused on developing therapies for degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration, and Parkinson's disease.
Explore Our Approach
Contact Us